Momenta Pharmaceuticals, Inc. (MNTA)

[investorgold2002]

Yes that was one of my 2 questions. Disappointing to say the least.
I was excited to see the Bofa analyst had modeled around 50m in expenses for 2012 soon after the Amphastar news. But Shea and wheeler disagree..25m corp G&A also seems excessive for such a small company considering it doesnt include salary for scientists. the excuse is FOB . but never ask them any details on FOB. entire industry is moving at lightening speed on this including doing phase 3 clinical trial(eg: Hospira)...and here these guys seem to be on drawing board. At least tell us some milestones(hide stuff that will aid competition)..